Okayama, Japan

Mayuko Koreishi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Ajinomoto Co., Ltd., Okayama University. Active years: 2011.



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mayuko Koreishi: Innovator in Aminoacylase Technology

Introduction

Mayuko Koreishi is a prominent inventor based in Okayama, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of aminoacylases. Her innovative work has led to advancements in the production of Nε-acyl-L-lysine, a compound with various applications in biotechnology.

Latest Patents

Koreishi holds a patent for an invention titled "Nε-acyl-L-lysine-specific aminoacylase." This invention provides an aminoacylase that exhibits superior abilities in specifically acylating and hydrolyzing the ε-amino group of lysine. The patent outlines a method for producing Nε-acyl-L-lysine by utilizing the aminoacylase on L-lysine and a carboxylic acid. She has 1 patent to her name, showcasing her expertise in this specialized area.

Career Highlights

Throughout her career, Mayuko Koreishi has worked with notable organizations, including Ajinomoto Co., Ltd. and Okayama University. Her roles in these institutions have allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Koreishi has collaborated with esteemed colleagues such as Kazuhiro Nakanishi and Koreyoshi Imamura. These partnerships have further enriched her research and innovation efforts.

Conclusion

Mayuko Koreishi is a trailblazer in the field of aminoacylase technology, with her patent and collaborations reflecting her commitment to advancing biochemistry. Her work continues to influence the scientific community and pave the way for future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…